Ethinyl Estradiol; Norgestimate Patent Expiration

Ethinyl Estradiol; Norgestimate is Used for preventing pregnancy. It was first introduced by Janssen Pharmaceuticals Inc in its drug Ortho Cyclen-21 on Dec 29, 1989. Other drugs containing Ethinyl Estradiol; Norgestimate are Ortho Tri-Cyclen Lo, Ortho Tri-Cyclen, Ortho Cyclen-28. 17 different companies have introduced drugs containing Ethinyl Estradiol; Norgestimate.


Ethinyl Estradiol; Norgestimate Patents

Given below is the list of patents protecting Ethinyl Estradiol; Norgestimate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ortho Tri-cyclen Lo US6214815

(Pediatric)

Triphasic oral contraceptive Dec 09, 2019

(Expired)

Janssen Pharms
Ortho Tri-cyclen Lo US6214815 Triphasic oral contraceptive Jun 09, 2019

(Expired)

Janssen Pharms



Ethinyl Estradiol; Norgestimate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ethinyl Estradiol; Norgestimate Generic API Manufacturers

Several generic applications have been filed for Ethinyl Estradiol; Norgestimate. The first generic version for Ethinyl Estradiol; Norgestimate was by Barr Laboratories Inc and was approved on Sep 25, 2002. And the latest generic version is by Novast Laboratories Ltd and was approved on Sep 2, 2022.

Given below is the list of companies who have filed for Ethinyl Estradiol; Norgestimate generic, along with the locations of their manufacturing plants worldwide.